Discover great EU-funded Innovations
Excellent Science INNOVATION
A novel dosimetry platform for personalized pediatric nuclear imaging applications.
SHARE:
Market Maturity: Exploring
These are innovations that are actively exploring value creation opportunities. Learn more
Market Creation Potential
This innovation was assessed by the JRC’s Market Creation Potential indicator framework as having a High” level of Market Creation Potential. Only innovations that are showing multiple signals of market creation potential are assigned a value under this indicator system. Learn more
Go to Market needs
Needs that, if addressed, can increase the chances this innovation gets to (or closer to) the market incude:
  • Prepare for Market entry
  • Secure capital
  • Scale-up market opportunities
Location of Key Innovators developing this innovation
Key Innovators
The EU-funded Research Project
This innovation was developed under the Horizon 2020 project ERROR with an end date of 31/12/2019
  • Read more about this project on CORDIS
Description of Project ERROR
The main objective of ERROR is to develop a new software tool, which will offer to the clinician the possibility to assess alternative imaging and therapeutic protocols, in real time, in silico, in order to minimize patient dose, while maintaining image quality of therapeutic effect. This tool will be designed, implemented and evaluated with specific focus on pediatric patients, since this is a rather sensitive target group, where dose considerations are high and no standard protocols and solutions exist. The project will exploit the new generation of computational anthropomorphic phantoms, in combination with well validated Monte Carlo simulations and Machine Learning Tools. In this way, it is envisaged that advanced, yet mature technologies will be integrated, to provide a novel tool, which can lead to a final product. The ERROR project brings together a multidisciplinary consortium of specialists in different areas of medical physics, biomedical engineering, physicians and computer engineers, who will join forces in order to design, implement and clinically assess a novel software tools, which initial focus in the optimization of diagnostic and therapeutic protocols for pediatric exams. Two new SMEs will provide their expertise, as well as investigate the ways to exploit project outcome. A well planned exchange program among academic and industrial partners will facilitate knowledge sharing, maximize collaborative work and finally achievement of project objectives. The consortium, being aware of the scientific and social importance of pediatric clinical applications, has planned a series of dissemination and training activities, aiming at making project knowledge and outcomes available to the scientific community and society.

Innnovation Radar's analysis of this innovation is based on data collected on 14/10/2019.
The unique id of this innovation in the European Commission's IT systems is: 18369